Novasep has appointed Michel Spagnol as its new president and CEO, succeeding Patrick Glaser who returns to the US.
Spagnol joins French contract manufacturing firm Novasep from Shasun, where he was president and chief technology officer.
Prior to Shasun, Spagnol spent his career at Rhodia in Lyon, France and New Jersey, US, where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as sales and marketing vice president of Rhodia Pharma Solutions.
He joins Novasep as the company looks to expand through investments in its manufacturing capabilities in both France and China.
“His track record in delivering customer driven solutions, his international and scientific background coupled with his extensive management experience, longstanding knowledge and relationships in the pharmaceutical industry will be strong assets for the company,” said Roger-Marc Nicoud, founder and non-executive chairman of the board of Novasep.